Researchclopedia
Research
Researchers
Institutions
Topics
Submit
About
Search...
⌘
K
Command Palette
Search for a command to run...
Back to research
Ranibizumab 0.5 mg treat-and-extend regimen for diabetic macular oedema: the RETAIN study
2015
168 citations
Journal Article
hybrid Open Access
Field-Weighted Citation Impact:
11.37
Ranibizumab 0.5 mg treat-and-extend regimen for diabetic macular oedema: the RETAIN study | Researchclopedia
·
Novartis (Switzerland)
Soumil Parikh
·
Novartis (Switzerland)
William John Stubbings
·
Novartis (Switzerland)
Andreas Wenzel
·
Novartis (Switzerland)
João Figueira
·
Association for Innovation and Biomedical Research on Light and Image
and the RETAIN Study Group